XML 30 R16.htm IDEA: XBRL DOCUMENT v3.25.2
Note 5 - Earnings Per Common Share
12 Months Ended
Jun. 30, 2025
Notes to Financial Statements  
Earnings Per Share [Text Block]

NOTE 5 EARNINGS PER SHARE

 

The following table presents the amounts used to compute basic and diluted earnings per common share, as well as the effect of dilutive potential common shares on weighted average shares outstanding:

 

 

(in thousands, except per share data)

               
                 

 

 

2025

   

2024

 
BASIC EARNINGS PER SHARE                
                 

Net Income

  $ 24,383     $ 24,977  
                 

Weighted average shares outstanding during the period, net of treasury shares

    28,808       27,981  
                 

Weighted average vested restricted stock units outstanding

    76       81  
                 

Weighted average shares outstanding in the Deferred Compensation Plan during the period

    1,019       987  

Weighted average shares outstanding

    29,903       29,049  
                 

Basic income per share

  $ 0.82     $ 0.86  
                 

DILUTED EARNINGS PER SHARE

               
                 

Net Income

  $ 24,383     $ 24,977  
                 

Weighted average shares outstanding

               
                 

Basic

    29,903       29,049  
                 

Effect of dilutive securities (a):

               

Impact of common shares to be issued under stock option plans, and Contingently issuable shares, if any

    929       1,019  

Weighted average shares outstanding

    30,832       30,068  
                 

Diluted income per share

  $ 0.79     $ 0.83  
                 

Anti-dilutive securities (b)

    261       54  

 

 

(a)

Calculated using the “Treasury Stock” method as if dilutive securities were exercised and the funds were used to purchase common shares at the average market price during the period.

 

 

(b)

Anti-dilutive securities were excluded in the computation of diluted earnings per share for the year ended June 30, 2025, and June 30, 2024, because the exercise price was greater than the fair market price of the common shares or because the assumed proceeds from the award’s exercise or vesting was greater than the average fair market price of the common shares.